A study investigating the effect of PCLO on antidepressant treatment efficacy in MDD patients found statistically significant differences in the combined dexamethasone/corticotropin-releasing hormone test results between patients with different genotypes at admission and after 4 weeks of treatment. The gene discussed is CRH; the disease is major depressive disorder.